Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
albenatide
(CJC-1134-PC) /
ConjuChem, Changshan Kaijiejian Biopharma
Welcome,
Profile
Billing
Logout
5 Diseases
2 Trials
2 Trials
7 News
||
||||||||
albenatide
(CJC-1134-PC) /
ConjuChem
Clinical, PK/PD data, Journal:
Safety, tolerability, pharmacodynamics and pharmacokinetics of CJC-1134-PC in healthy Chinese subjects and type-2 diabetic subjects.
(Pubmed Central) - Feb 12, 2022
The safety and PK/PD profiles of weekly CJC-1134-PC doses support Phase II studies with guidance on optimal dose selection. The clinical trial registration number for this work is ChiCTR-IPC-15007190.
||||||||||
albenatide
(CJC-1134-PC) /
ConjuChem, Changshan Kaijiejian Biopharma
Trial primary completion date, Monotherapy:
Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy
(clinicaltrials.gov) - Jul 19, 2017
P2
, N=73, Terminated,
Sponsor: ConjuChem
The clinical trial registration number for this work is ChiCTR-IPC-15007190. Trial primary completion date: Dec 2012 --> May 2012
|
|||||||||
albenatide
(CJC-1134-PC) /
ConjuChem, Changshan Kaijiejian Biopharma
Trial termination, Monotherapy:
Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy
(clinicaltrials.gov) - Mar 7, 2012
P2
, N=74, Terminated,
Sponsor: ConjuChem
Trial primary completion date: Dec 2012 --> May 2012 Recruiting --> Terminated; Business decision
||||||||||
albenatide
(CJC-1134-PC) /
ConjuChem, Changshan Kaijiejian Biopharma
Enrollment change, Monotherapy:
Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy
(clinicaltrials.gov) - Mar 7, 2012
P2
, N=74, Terminated,
Sponsor: ConjuChem
Recruiting --> Terminated; Business decision N=225 --> 74
|
|||||||||
albenatide
(CJC-1134-PC) /
ConjuChem, Changshan Kaijiejian Biopharma
New P2 trial, Monotherapy:
Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy
(clinicaltrials.gov) - Oct 19, 2011
P2
, N=74, Terminated,
Sponsor: ConjuChem